Pamela S. Fink - Concepedia

Author

Pamela S. Fink

Wright State University

Also Known As

P Fink, P S Fink, P. Fink, P. S. Fink, P.S. Fink, Pamela Fink, Pamela S Fink, Pamela S. Fink, Pamela S. Fink

Publications

Citations

H-Index

Concepts

All Affiliations

Wright State University Pearl River Community College Pfizer (United States)Cornell University Computational Physics (United States)

About

Pamela S. Fink is an author at Wright State University specializing in microbiology, medicine, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	470
2	Health Sciences	2	2	86
3	Natural Sciences	2	2	28
4	Biochemistry	2	2	39
5	Engineering	1	1	10

Pamela S. Fink

Publications

765

Citations

H-Index

Page 1

	Year	Citations
Sequence Diversity of the Factor H Binding Protein Vaccine Candidate in Epidemiologically Relevant Strains of Serogroup B<i>Neisseria meningitidis</i> Ellen Murphy, Lubomira Andrew, Kwok‐Leung Lee, The Journal of Infectious Diseases	2009	191
Capsular polysaccharides are an important immune evasion mechanism for<i>Staphylococcus aureus</i> Jasdeep S. Nanra, Sandra Buitrago, Shomari Crawford, Human Vaccines & Immunotherapeutics Severe LifeMicrobial PathogensInnate Immune SystemImmunologyStaphylococcus Aureus	2013	120
Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086 Alessandro Mascioni, Breagh E. Bentley, Rosaria Camarda, Journal of Biological Chemistry	2008	71
Evaluation of Approaches to Monitor Staphylococcus aureus Virulence Factor Expression during Human Disease Wouter Rozemeijer, Pamela S. Fink, Eduardo A. Peña Rojas, PLoS ONE Pathogen DetectionMicrobial PathogensImmunologyStaphylococcus AureusBacterial Pathogens	2015	47
Challenges for the evaluation of<i>Staphylococcus aureus</i>protein based vaccines: Monitoring antigenic diversity Ellen Murphy, Shuo Lin, Lorna Nuñez, Human Vaccines ImmunologyImmunodominancePathologyMonitoring Antigenic DiversityS. Aureus Disease	2011	44
Heterogeneous in vivo expression of clumping factor A and capsular polysaccharide by Staphylococcus aureus: Implications for vaccine design Jasdeep S. Nanra, Yekaterina Timofeyeva, Sandra Buitrago, Vaccine VaccinationMucosal VaccinationMicrobial PathogensMedicineVaccine Target	2009	40
Polyene Antibiotics from <i>Streptomyces mediocidicus</i> Ping Cai, Fangming Kong, Pamela S. Fink, Journal of Natural Products Medicinal ChemistryAntimicrobial Drug DiscoveryBioorganic ChemistryPolyene AntibioticsAntibiotics	2007	39
Tn5 mutagenesis of the Salmonella typhimurium 100 kb plasmid: definition of new virulence regions Donata Sizemore, Pamela S. Fink, Jonathon T. Ou, Microbial Pathogenesis New Virulence RegionsVirulence FactorTn5 MutagenesisPathogenesisSalmonella Typhimurium 100	1991	23
NMR dynamics and antibody recognition of the meningococcal lipidated outer membrane protein LP2086 in micellar solution Alessandro Mascioni, Franklin J. Moy, Lisa K. McNeil, Biochimica et Biophysica Acta (BBA) - Biomembranes Proteinlipid InteractionAntibody RecognitionBiochemistryNmr DynamicsMicrobiology	2009	21
Bacteria with defective rho factors suppress the effects ofN mutations in bacteriophage λ John P. Richardson, Pamela S. Fink, Kerry T. Blanchard, Molecular and General Genetics MGG GeneticsBacteriologyBacteriophageMolecular BiologyDefective Rho Factors	1977	19

Page 1